AGP Picks
View all

Today's News: Middle East
Provided by AGP

Today's News: Middle East: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today's News: Middle East.

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

November 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30

Press releases published on November 4, 2026

Atico Begins Pre-Construction at La Plata Project with the Commencement of Archaeological Activities and Construction of a Wildlife Transit Center
Nov. 4, 2026

Atico Begins Pre-Construction at La Plata Project with the Commencement of Archaeological Activities and Construction of a Wildlife Transit Center

Indeterminate GlobeNewswire
Helium Evolution Enters Into Investor Relations Agreement and Amends Option Agreement
Nov. 4, 2026

Helium Evolution Enters Into Investor Relations Agreement and Amends Option Agreement

Indeterminate GlobeNewswire
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Nov. 4, 2026

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Agomab to Participate in Upcoming Investor Conferences
Nov. 4, 2026

Agomab to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Relay Therapeutics Reports Third Quarter 2026 Financial Results and Corporate Updates
Nov. 4, 2026

Relay Therapeutics Reports Third Quarter 2026 Financial Results and Corporate Updates

Indeterminate GlobeNewswire
PROCEPT BioRobotics Reports Third Quarter 2026 Financial Results and Reaffirms 2026 Financial Guidance
Nov. 4, 2026

PROCEPT BioRobotics Reports Third Quarter 2026 Financial Results and Reaffirms 2026 Financial Guidance

Indeterminate GlobeNewswire
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Nov. 4, 2026

Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Tenaya Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Nov. 4, 2026

Tenaya Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Kailera Reports Third Quarter 2026 Financial Results and Provides Business Updates
Nov. 4, 2026

Kailera Reports Third Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire
Alamar Biosciences to Participate in Upcoming Investor Conferences
Nov. 4, 2026

Alamar Biosciences to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2026
Nov. 4, 2026

Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2026

Indeterminate GlobeNewswire
AEPCO Completes 4 MWp Solar PV Project at J2 Mall car park in Kuwait
Nov. 4, 2026

AEPCO Completes 4 MWp Solar PV Project at J2 Mall car park in Kuwait

Indeterminate EIN Presswire
Revolution Medicines Reports Third Quarter 2026 Financial Results and Update on Corporate Progress
Nov. 4, 2026

Revolution Medicines Reports Third Quarter 2026 Financial Results and Update on Corporate Progress

Indeterminate GlobeNewswire
BioCryst to Present at Upcoming Investor Conferences
Nov. 4, 2026

BioCryst to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov. 4, 2026

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov. 4, 2026

Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Celldex to Present at Upcoming Investor Conferences
Nov. 4, 2026

Celldex to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire
Arvinas to Present Preliminary Clinical Data from Early Monotherapy Dose Escalation Cohorts in the Phase 1 Trial for ARV-393 (Zaloblideg), a PROTAC BCL6 Degrader, at the 2026 American Society of Hematology (ASH®) Annual Meeting
Nov. 4, 2026

Arvinas to Present Preliminary Clinical Data from Early Monotherapy Dose Escalation Cohorts in the Phase 1 Trial for ARV-393 (Zaloblideg), a PROTAC BCL6 Degrader, at the 2026 American Society of Hematology (ASH®) Annual Meeting

Indeterminate GlobeNewswire
MENA Construction Summit 2026 and UNBX 2.0 Join Forces in Dubai This November
Nov. 4, 2026

MENA Construction Summit 2026 and UNBX 2.0 Join Forces in Dubai This November

Indeterminate EIN Presswire
Dubai-Developed IDEALX Launches Enhanced Digital Platform for Australian Investors
Nov. 4, 2026

Dubai-Developed IDEALX Launches Enhanced Digital Platform for Australian Investors

Indeterminate EIN Presswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Today's News: Middle East

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.